Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging

Clinical Nuclear Medicine

Volumn 29, Issue 11, 2004, Pages 685-688

  Kumar, Rakesh ^a   Bhargava, Peeyush ^a   Zhuang, Hongming ^a   Yu, Jian Q ^a   Schuster, Stephen J ^a   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diffuse large B cell lymphoma; FDG PET; Follicular lymphoma; Mantle cell lymphoma; Non Hodgkin lymphoma; Spontaneous cancer regression

Indexed keywords

FLUORODEOXYGLUCOSE; RADIOPHARMACEUTICAL AGENT; TRACER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEOPLASM REGRESSION, SPONTANEOUS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 6944224092     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200411000-00002     Document Type: Article

References (27)

1. Gattiker HH, Wiltshaw E, Galton DA. Spontaneous regression in non-Hodgkin's lymphoma. Cancer. 1980;45:2627-2632.
2. Krikorian JG, Portlock CS, Cooney P, et al. Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases. Cancer. 1980;46:2093-2099.
3. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med. 1984;311:1471-1475.
4. Grem JL, Hafez GR, Brandenburg JH, et al. Spontaneous remission in diffuse large cell lymphoma. Cancer. 1986;57:2042-2044.
5. Savarrio L, Gibson J, Dunlop DJ, et al. Spontaneous regression of an anaplastic large cell lymphoma in the oral cavity: first reported case and review of the literature. Oral Oncol. 1999;35:609-613.
6. Keogh PV, Fisher V, Flint SR. Resolution of oral non-Hodgkin's lymphoma by reduction of immunosuppressive therapy in a renal allograft recipient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:697-701.
7. Kumamoto M, Nakamine H, Hara T, et al. Spontaneous complete regression of high-grade non-Hodgkin's lymphoma. Morphologic, immunohistochemical, and gene amplification analyses. Cancer. 1994;74:3023-3028.
8. Cremerius U, Fabry U, Kroll U, et al. Clinical value of FDG PET for therapy monitoring of malignant lymphoma- results of a retrospective study in 72 patients. Nuklearmedizin. 1999;38:24-30.
9. Matthies A, Schuster SJ, Alavi A. Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography. Clin Lymphoma. 2001;1:303-306.
10. De Wit M, Bumann D, Beyer W, et al. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Ann Oncol. 1997;8(suppl 1):57-60.
11. Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-FDG for post treatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than computed tomography scan imaging. Blood. 1999;94:429-433.
12. Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 2003;101:3875-3876.
13. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer. 1982;49:2112-2135.
14. Chan WC, Armitage JO, Gascoyne R, et al. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
15. Bastion Y, Sebban C, Berger F, et al. Incidence, predictive factors and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol. 1997;15:1587-1594.
16. Pileri SA, Dirnhofer S, Went PH, et al. Diffuse large B cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology. 2002;41:482-509.
17. Bosch Bosch F, Lopez-Guillermo A, Campo E, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer. 1998;82:567-575.
18. Fujiwara T, Kawamura M, Sasaki A, et al. Transient spontaneous regression of aggressive non-Hodgkin's lymphoma confined to adrenal glands. Ann Hematol. 2001;80:561-564.
19. Salem I, Durai D, Murphy JK, et al. Regression of primary high grade gastric B cell lymphoma following Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2001;13:1375-1378.
20. Wolf JW. Prolonged spontaneous remission of case of malignant lymphoma. Missouri Med. 1989;86:275-277.
21. Tamura J, Jinbo T, Take H, et al. Spontaneous regression in B cell, diffuse large cell type non-Hodgkin lymphoma. Acta Haematol. 1993;90:46-47.
22. Wiernik PH. Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr. 1976;44:35-38.
23. Even-Sapir E, Israel O. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(suppl 1):S65-S81.
24. Machida K, Inoue Y, Honda N, et al. Spontaneous regression of chest wall malignant lymphoma. Presentation on Ga-67 imaging. Clin Nucl Med. 2003;28:405-407.
25. Kostakoglu L, Leonard JP, Kuji I, et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer. 2002;94:879-888.
26. De Wit M, Bumann D, Beyer W, et al. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Ann Oncol. 1997;8:57-60.
27. Blum RH, Seymour JF, Wirth A, et al. Frequent impact of [18F] fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Clin Lymphoma. 2003;4:43-49.